Skip to main content
. 2021 Jan 9;10(1):22–34. doi: 10.5492/wjccm.v10.i1.22

Table 3.

Change in laboratory parameters for survivors

Parameters
Pre CytoSorb ® therapy
Post CytoSorb ® therapy
P value
Hb, g/dL 10.01 ± 2.20 9.28 ± 1.53 0.1830
HCT, % 29.74 ± 8.4 25.75 ± 7.67 0.0909
Leucocytes, µL 16724 ± 5425 11215 ± 3317 0.00011
Platelets, cells/mm3 139256 ± 88029 181203 ± 181381 0.2938
S. Creatinine, mg/dL 3.13 ± 1.92 2.08 ± 1.02 0.01901
S. Lactate, mmol/L 4.75 ± 2.77 2.88 ± 2.39 0.01201
SGOT, U/L 488.44 ± 1570.42 369.95 ± 1134.74 0.7661
SGPT, U/L 192.72 ± 298.99 145.90 ± 236.97 0.5503
BUN, mg/dL 76.21 ± 61.88 62.39 ± 52.28 0.4076
Bilirubin, mg/dL 9.91 ± 36.77 8.35 ± 31.36 0.8730
Sodium, mmol/L 134.38 ± 25.69 134.32 ± 6.20 0.9908
Potassium, mmol/L 3.98 ± 0.95 3.73 ± 1.05 0.3723
Albumin, g/L 2.65 ± 0.93 2.71 ± 0.95 0.8261
Arterial pH 7.35 ± 0.100 7.36 ± 0.105 0.7291
Bicarbonate 24.89 ± 10.71 24.75 ± 9.21 0.9599
1

Significant value P < 0.05, all values are defined as mean ± SD.

BUN: Blood urea nitrogen; Hb: Hemoglobin; HCT: Hematocrit; SD: Standard deviation; SGOT: Serum glutamic oxaloacetic transaminase; SGPT: Serum glutamic-pyruvic transaminase.